
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $366K | $359K | $386K | $488K | $683K | |
Revenue Growth (YoY) | 49.61% | -1.91% | 7.52% | 26.43% | 39.96% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $11.2M | $17.4M | $27.1M | $32.9M | $36.9M | |
Selling, General & Admin | $8.2M | $11.8M | $13.2M | $13M | $12.5M | |
Other Inc / (Exp) | -$309K | $300K | -$383K | -$98K | -$39K | |
Operating Expenses | $19.5M | $29.2M | $40.3M | $45.9M | $49.3M | |
Operating Income | -$19.1M | -$28.9M | -$39.9M | -$45.4M | -$48.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | |
Basic EPS (Cont. Ops) | -$1.08 | -$0.73 | -$0.89 | -$0.93 | -$0.95 | |
Diluted EPS (Cont. Ops) | -$1.08 | -$0.73 | -$0.89 | -$0.93 | -$0.95 | |
Weighted Average Basic Share | $20.9M | $39M | $43.6M | $44.7M | $47.7M | |
Weighted Average Diluted Share | $20.9M | $39M | $43.6M | $44.7M | $47.7M | |
EBITDA | -$18.8M | -$28.4M | -$39.7M | -$45M | -$48.2M | |
EBIT | -$19.3M | -$28.9M | -$39.9M | -$45.4M | -$48.7M | |
Revenue (Reported) | $366K | $359K | $386K | $488K | $683K | |
Operating Income (Reported) | -$19.1M | -$28.9M | -$39.9M | -$45.4M | -$48.7M | |
Operating Income (Adjusted) | -$19.3M | -$28.9M | -$39.9M | -$45.4M | -$48.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $72K | $74K | $83K | $205K | $109K | |
Revenue Growth (YoY) | 5.88% | 2.78% | 12.16% | 146.99% | -46.83% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.3M | $7.2M | $9.1M | $8M | $10.5M | |
Selling, General & Admin | $2.2M | $3.9M | $3.1M | $3.1M | $4M | |
Other Inc / (Exp) | $206K | -$49K | -$111K | -$4K | $7K | |
Operating Expenses | $5.5M | $11.1M | $12.1M | $11.1M | $14.5M | |
Operating Income | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Basic EPS (Cont. Ops) | -$0.14 | -$0.25 | -$0.25 | -$0.22 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.14 | -$0.25 | -$0.25 | -$0.22 | -$0.20 | |
Weighted Average Basic Share | $37.2M | $43.2M | $44.7M | $44.7M | $66.5M | |
Weighted Average Diluted Share | $37.2M | $43.2M | $44.7M | $44.7M | $66.5M | |
EBITDA | -$5.3M | -$11M | -$12M | -$10.7M | -$14.2M | |
EBIT | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Revenue (Reported) | $72K | $74K | $83K | $205K | $109K | |
Operating Income (Reported) | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Operating Income (Adjusted) | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $370K | $361K | $395K | $610K | $588K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $11.8M | $21.3M | $29M | $31.8M | $39.3M | |
Selling, General & Admin | $9M | $13.5M | $12.3M | $13.1M | $13.4M | |
Other Inc / (Exp) | -$103K | $32K | -$445K | $9K | -$28K | |
Operating Expenses | $20.8M | $34.8M | $41.3M | $44.9M | $52.7M | |
Operating Income | -$20.4M | -$34.5M | -$40.9M | -$44.3M | -$52.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$20.4M | -$34.1M | -$38.9M | -$40.2M | -$48.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$20.4M | -$34.1M | -$38.9M | -$40.2M | -$48.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$20.4M | -$34.1M | -$38.9M | -$40.2M | -$48.9M | |
Basic EPS (Cont. Ops) | -$1.02 | -$0.82 | -$0.89 | -$0.90 | -$0.92 | |
Diluted EPS (Cont. Ops) | -$1.02 | -$0.82 | -$0.89 | -$0.90 | -$0.92 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$20.2M | -$34.1M | -$40.6M | -$43.7M | -$51.7M | |
EBIT | -$20.6M | -$34.5M | -$40.9M | -$44.3M | -$52.1M | |
Revenue (Reported) | $370K | $361K | $395K | $610K | $588K | |
Operating Income (Reported) | -$20.4M | -$34.5M | -$40.9M | -$44.3M | -$52.1M | |
Operating Income (Adjusted) | -$20.6M | -$34.5M | -$40.9M | -$44.3M | -$52.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $72K | $74K | $83K | $205K | $109K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.3M | $7.2M | $9.1M | $8M | $10.5M | |
Selling, General & Admin | $2.2M | $3.9M | $3.1M | $3.1M | $4M | |
Other Inc / (Exp) | $206K | -$49K | -$111K | -$4K | $7K | |
Operating Expenses | $5.5M | $11.1M | $12.1M | $11.1M | $14.5M | |
Operating Income | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Basic EPS (Cont. Ops) | -$0.14 | -$0.25 | -$0.25 | -$0.22 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.14 | -$0.25 | -$0.25 | -$0.22 | -$0.20 | |
Weighted Average Basic Share | $37.2M | $43.2M | $44.7M | $44.7M | $66.5M | |
Weighted Average Diluted Share | $37.2M | $43.2M | $44.7M | $44.7M | $66.5M | |
EBITDA | -$5.3M | -$11M | -$12M | -$10.7M | -$14.2M | |
EBIT | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Revenue (Reported) | $72K | $74K | $83K | $205K | $109K | |
Operating Income (Reported) | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M | |
Operating Income (Adjusted) | -$5.4M | -$11.1M | -$12.1M | -$10.9M | -$14.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $131M | $11.9M | $16.3M | $21.7M | $51.5M | |
Short Term Investments | -- | $128.9M | $88.9M | $53.2M | $40.3M | |
Accounts Receivable, Net | $320K | $535K | $771K | $288K | $773K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.1M | $4.8M | $5.2M | $2.3M | $2.5M | |
Total Current Assets | $133.4M | $146.1M | $111.3M | $77.4M | $95.1M | |
Property Plant And Equipment | $967K | $3.2M | $3.5M | $2.9M | $2.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $404K | $239K | $1.4M | $1.3M | $69K | |
Total Assets | $134.7M | $149.5M | $116.2M | $81.6M | $97.2M | |
Accounts Payable | $1.4M | $1.4M | $2M | $2M | $4.8M | |
Accrued Expenses | $1.9M | $2.7M | $3.3M | $5M | $5.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $860K | $551K | $675K | $691K | $710K | |
Other Current Liabilities | $42K | $42K | -- | -- | -- | |
Total Current Liabilities | $6.1M | $6.6M | $7.8M | $10.4M | $13.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.6M | $9.1M | $9.8M | $11.9M | $14.2M | |
Common Stock | $5K | $5K | $4K | $4K | $7K | |
Other Common Equity Adj | -- | -$142K | -$395K | -$67K | $34K | |
Common Equity | $128.2M | $140.4M | $106.3M | $69.7M | $82.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $128.2M | $140.4M | $106.3M | $69.7M | $82.9M | |
Total Liabilities and Equity | $134.7M | $149.5M | $116.2M | $81.6M | $97.2M | |
Cash and Short Terms | $131M | $140.8M | $105.3M | $74.8M | $91.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $14.7M | $20.1M | $15M | $18.7M | $24.1M | |
Short Term Investments | $110.9M | $109.3M | $82M | $48.5M | $55.8M | |
Accounts Receivable, Net | $242K | $447K | $676K | $393K | $405K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.7M | $6M | $4.1M | $2.4M | $2.4M | |
Total Current Assets | $128.6M | $135.8M | $101.8M | $70M | $82.7M | |
Property Plant And Equipment | $765K | $3.2M | $3.4M | $2.8M | $1.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $238K | $188K | $1.4M | $1.3M | $257K | |
Total Assets | $129.6M | $139.2M | $106.5M | $74M | $84.8M | |
Accounts Payable | $803K | $1.3M | $2.9M | $5.2M | $3.6M | |
Accrued Expenses | $3M | $3.4M | $3.6M | $4.7M | $6.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $635K | $665K | $679K | $696K | $716K | |
Other Current Liabilities | $42K | -- | -- | -- | -- | |
Total Current Liabilities | $4.5M | $6.7M | $8.1M | $11.8M | $13.3M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.8M | $9.1M | $10M | $13.1M | $13.9M | |
Common Stock | $5K | $4K | $4K | $4K | $7K | |
Other Common Equity Adj | -$67K | -$748K | -$76K | -$132K | $27K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $124.8M | $130.1M | $96.5M | $60.9M | $70.9M | |
Total Liabilities and Equity | $129.6M | $139.2M | $106.5M | $74M | $84.8M | |
Cash and Short Terms | $125.6M | $129.4M | $97M | $67.2M | $79.9M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | |
Depreciation & Amoritzation | $466K | $451K | $236K | $398K | $404K | |
Stock-Based Compensation | $1.8M | $3.2M | $4.3M | $4.5M | $4.8M | |
Change in Accounts Receivable | -$117K | -$215K | -$236K | $483K | -$484K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$16.3M | -$23M | -$33.8M | -$30.9M | -$37.7M | |
Capital Expenditures | $211K | $205K | $1M | $582K | $80K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$211K | -$131.4M | $38.1M | $36.2M | $13.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $305K | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$305K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8K | -- | -- | -- | -- | |
Cash From Financing | $137.3M | $35.5M | $75K | -- | $53.8M | |
Beginning Cash (CF) | $10.2M | $131M | $11.9M | $16.3M | $21.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $120.8M | -$119M | $4.4M | $5.3M | $29.8M | |
Ending Cash (CF) | $131M | $11.9M | $16.3M | $21.7M | $51.5M | |
Levered Free Cash Flow | -$16.5M | -$23.2M | -$34.8M | -$31.5M | -$37.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Depreciation & Amoritzation | $119K | $31K | $90K | $236K | $228K | |
Stock-Based Compensation | $268K | $1.2M | $1.1M | $1.1M | $1.4M | |
Change in Accounts Receivable | $79K | $88K | $95K | -$105K | $368K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.9M | -$10.2M | -$8.7M | -$7.7M | -$12.8M | |
Capital Expenditures | -- | $171K | $8K | $80K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$111.7M | $18.4M | $7.3M | $4.6M | -$14.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $1.3M | -- | -- | $107K | $3K | |
Beginning Cash (CF) | $131M | $11.9M | $16.3M | $21.7M | $51.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$116.3M | $8.1M | -$1.3M | -$3M | -$27.4M | |
Ending Cash (CF) | $14.7M | $20.1M | $15M | $18.7M | $24.1M | |
Levered Free Cash Flow | -$5.9M | -$10.4M | -$8.7M | -$7.8M | -$12.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$20.4M | -$34.1M | -$38.9M | -$40.2M | -$48.9M | |
Depreciation & Amoritzation | $466K | $363K | $295K | $544K | $396K | |
Stock-Based Compensation | $1.9M | $4.1M | $4.2M | $4.6M | $5M | |
Change in Accounts Receivable | -$135K | -$206K | -$229K | $283K | -$11K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$18.8M | -$27.4M | -$32.2M | -$30M | -$42.7M | |
Capital Expenditures | $211K | $376K | $843K | $654K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$111.9M | -$1.4M | $27.1M | $33.5M | -$5.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $136.1M | $34.2M | $75K | $107K | $53.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $5.4M | $5.4M | -$5M | $3.6M | $5.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$19M | -$27.8M | -$33.1M | -$30.6M | -$42.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.2M | -$11M | -$11.2M | -$10M | -$13.4M | |
Depreciation & Amoritzation | $119K | $31K | $90K | $236K | $228K | |
Stock-Based Compensation | $268K | $1.2M | $1.1M | $1.1M | $1.4M | |
Change in Accounts Receivable | $79K | $88K | $95K | -$105K | $368K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.9M | -$10.2M | -$8.7M | -$7.7M | -$12.8M | |
Capital Expenditures | -- | $171K | $8K | $80K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$111.7M | $18.4M | $7.3M | $4.6M | -$14.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $1.3M | -- | -- | $107K | $3K | |
Beginning Cash (CF) | $131M | $11.9M | $16.3M | $21.7M | $51.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$116.3M | $8.1M | -$1.3M | -$3M | -$27.4M | |
Ending Cash (CF) | $14.7M | $20.1M | $15M | $18.7M | $24.1M | |
Levered Free Cash Flow | -$5.9M | -$10.4M | -$8.7M | -$7.8M | -$12.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.